Jacob Pierce

Oct 31, 2024 | jamanetwork.com | Jacob Pierce |Muthiah Vaduganathan |Gregg C. Fonarow |Uchechukwu Ikeaba

Key PointsQuestion  What is the prevalence and variability of sodium-glucose cotransporter-2 inhibitor (SGLT2i) use among patients with heart failure with reduced ejection fraction (HFrEF) in the US? Findings  In this cohort study including 49 399 patients hospitalized for HFrEF in the Get With The Guidelines–Heart Failure registry, 1 in 5 patients were discharged with prescriptions for SGLT2i therapy; rates were similarly low in patients with comorbid type 2 diabetes and chronic kidney disease.

Sep 23, 2024 | valawyersweekly.com | Jacob Pierce

Type of action: Medical malpracticeInjuries alleged: Hypoxic brain injury and permanent cognitive impairmentsCourt: Fairfax County Circuit CourtCase no.: 2022-12235Tried before: JuryName of judge or mediator: Judge Richard E. GardinerDate resolved: 4/3/2024Demand: $3,000,000Verdict or settlement: VerdictAmount: $0 (defense)Attorneys for defendant: Byron J. Mitchell and Jacob Pierce, AlexandriaDescription of case: Thuan Truong, age 82, suffered from debilitating chronic low back pain.

Jun 14, 2024 | journals.plos.org | Adovich S. Rivera |Jacob Pierce |Arjun Sinha |Anna E. Pawlowski

Citation: Rivera AS, Pierce JB, Sinha A, Pawlowski AE, Lloyd-Jones DM, Lee YC, et al. (2024) Designing target trials using electronic health records: A case study of second-line disease-modifying anti-rheumatic drugs and cardiovascular disease outcomes in patients with rheumatoid arthritis. PLoS ONE 19(6): e0305467.

Mar 25, 2024 | jacc.org | Stephen Greene |Iyanuoluwa Ayodele |Jacob Pierce |Muhammad Khan

ABSTRACTBackgroundUS nationwide estimates of the proportion of patients newly diagnosed with heart failure with reduced ejection fraction (HFrEF) eligible for quadruple medical therapy, and the associated benefits of rapid implementation, are not well characterized. ObjectivesThis study sought to characterize the degree to which patients newly diagnosed with HFrEF are eligible for quadruple medical therapy, and the projected benefits of in-hospital initiation.

Aug 15, 2023 | onlinelibrary.wiley.com | Jacob Pierce |Javed Butler |Baylor Scott |Stephen Greene

Corresponding Author Stephen J. Greene MD Division of Cardiology, Duke University School of Medicine, Durham, NC, USA Duke Clinical Research Institute, Durham, NC, USA Corresponding author. Stephen J Greene, MD, Duke Clinical Research Institute, 300 West Morgan Street, Durham, NC 27701; telephone: 919-684-8111; fax: 919-668-7078; Email: [email protected]; Twitter: @SJGreene_md, @DCRINewsSearch for more papers by this author